These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 16522552

  • 1. Thalassemia major-- on the verge of bleeding or thrombosis?
    Naithani R, Chandra J, Narayan S, Sharma S, Singh V.
    Hematology; 2006 Feb; 11(1):57-61. PubMed ID: 16522552
    [Abstract] [Full Text] [Related]

  • 2. Lupus anticoagulant and anticardiolipin antibodies in polytransfused beta thalassemia major.
    Sharma S, Raina V, Chandra J, Narayan S, Sharma S.
    Hematology; 2006 Aug; 11(4):287-90. PubMed ID: 17178669
    [Abstract] [Full Text] [Related]

  • 3. Thrombin activatable fibrinolysis inhibitor (TAFI): relationship to hemostatic alteration in patients with beta-thalassemia.
    Mokhtar GM, Matter RM, Shawki H, Abdel Aziz MM.
    Pediatr Hematol Oncol; 2010 Aug; 27(5):363-73. PubMed ID: 20670166
    [Abstract] [Full Text] [Related]

  • 4. Thrombin Activable Fibrinolysis Inhibitor in Beta Thalassemia.
    Chhikara A, Sharma S, Chandra J, Nangia A.
    Indian J Pediatr; 2017 Jan; 84(1):25-30. PubMed ID: 27487812
    [Abstract] [Full Text] [Related]

  • 5. Hemostatic alterations in splenectomized and non-splenectomized patients with beta-thalassemia/hemoglobin E disease.
    Tripatara A, Jetsrisuparb A, Teeratakulpisarn J, Kuaha K.
    Thromb Res; 2007 Jan; 120(6):805-10. PubMed ID: 17382994
    [Abstract] [Full Text] [Related]

  • 6. Hemostatic profile in nephrotic syndrome.
    Anand NK, Chand G, Talib VH, Chellani H, Pande J.
    Indian Pediatr; 1996 Dec; 33(12):1005-12. PubMed ID: 9141800
    [Abstract] [Full Text] [Related]

  • 7. Premature atherosclerosis in children with beta-thalassemia major: New diagnostic marker.
    Sherief LM, Dawood O, Ali A, Sherbiny HS, Kamal NM, Elshanshory M, Alazez OA, Alhady MA, Nour M, Mokhtar WA.
    BMC Pediatr; 2017 Mar 09; 17(1):69. PubMed ID: 28279156
    [Abstract] [Full Text] [Related]

  • 8. Hypercoagulable state in five thalassemia intermedia patients.
    Bhattacharyya M, Kannan M, Chaudhry VP, Mahapatra M, Pati H, Saxena R.
    Clin Appl Thromb Hemost; 2007 Oct 09; 13(4):422-7. PubMed ID: 17911195
    [Abstract] [Full Text] [Related]

  • 9. Protein C and protein S deficiency in thalassemic patients.
    Shirahata A, Funahara Y, Opartkiattikul N, Fucharoen S, Laosombat V, Yamada K.
    Southeast Asian J Trop Med Public Health; 1992 Oct 09; 23 Suppl 2():65-73. PubMed ID: 1298996
    [Abstract] [Full Text] [Related]

  • 10. Relationship of hepatic and renal dysfunction with haemorrheological parameters in Plasmodium falciparum malaria.
    Misra DP, Das S, Pattnaik M, Singh SC, Jena RK.
    J Assoc Physicians India; 2011 Sep 09; 59():552-6. PubMed ID: 22334967
    [Abstract] [Full Text] [Related]

  • 11. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C.
    Clin Endocrinol (Oxf); 2006 Mar 09; 64(3):323-9. PubMed ID: 16487444
    [Abstract] [Full Text] [Related]

  • 12. Alterations of anticoagulant proteins and soluble endothelial protein C receptor in thalassemia patients of Chinese origin.
    Huang Y, Long Y, Deng D, Liu Z, Liang H, Sun N, Xu Y, Lai Y, Cheng P.
    Thromb Res; 2018 Dec 09; 172():61-66. PubMed ID: 30384036
    [Abstract] [Full Text] [Related]

  • 13. Correlation of hepcidin level with insulin resistance and endocrine glands function in major thalassemia.
    Al-Hakeim HK, Al-Khakani MM, Al-Kindi MA.
    Adv Clin Exp Med; 2015 Dec 09; 24(1):69-78. PubMed ID: 25923089
    [Abstract] [Full Text] [Related]

  • 14. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG, Nguyen KT, Soundar E, Kostousov V, Bomgaars L, Moise A, Hui SK, Teruya J.
    Pediatr Crit Care Med; 2014 Jun 09; 15(5):e198-205. PubMed ID: 24614609
    [Abstract] [Full Text] [Related]

  • 15. Study of Serum Immunoglobulin Levels and T lymphocyte Subsets in Children with Beta Thalassemia with Iron Overload in Egypt.
    Hagag AA, Elgamasy MA, Abd Elbar ES.
    Egypt J Immunol; 2016 Jan 09; 23(1):97-105. PubMed ID: 28502157
    [Abstract] [Full Text] [Related]

  • 16. Haemostatic disorders in nonsplenectomized and splenectomized thalassaemic children.
    Shebl SS, el-Sharkawy HM, el-Fadaly NH.
    East Mediterr Health J; 1999 Nov 09; 5(6):1171-7. PubMed ID: 11924107
    [Abstract] [Full Text] [Related]

  • 17. Abnormal glucose tolerance in Egyptian beta-thalassemic patients: possible association with genotyping.
    Khalifa AS, Salem M, Mounir E, El-Tawil MM, El-Sawy M, Abd Al-Aziz MM.
    Pediatr Diabetes; 2004 Sep 09; 5(3):126-32. PubMed ID: 15450007
    [Abstract] [Full Text] [Related]

  • 18. High transfusion in children with beta-thalassemia/Hb E: clinical and laboratory assessment of 18 cases.
    Torcharus K, Withayathawornwong W, Sriphaisal T, Krutvacho T, Arnutti P, Suwanasophorn C.
    Southeast Asian J Trop Med Public Health; 1993 Sep 09; 24 Suppl 1():96-9. PubMed ID: 7886617
    [Abstract] [Full Text] [Related]

  • 19. What regulates hepcidin in poly-transfused β-Thalassemia Major: erythroid drive or store drive?
    Chauhan R, Sharma S, Chandra J.
    Indian J Pathol Microbiol; 2014 Sep 09; 57(1):39-42. PubMed ID: 24739829
    [Abstract] [Full Text] [Related]

  • 20. Coagulation defects in thalassemic patients.
    Abosdera MM, Almasry AE, Abdel-Moneim ES.
    Pediatr Neonatol; 2017 Oct 09; 58(5):421-424. PubMed ID: 28351558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.